The Ministry of Chemicals and Fertilizers (MoC&F) on November 09, 2026, issued a notification regarding caps on trade margins for 137 anti-cancer drugs to reduce medicine prices.
The following has been stated: -
•The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the MRP of 137 anti-cancer drugs based on the recommendations of an Expert Committee constituted by the Directorate General of Health Services (DGHS) on October 17, 2026, effective November 09, 2026.
•As of November 08, 2026, 85 pharmaceutical companies have reported revised MRPs for 1,364 formulations covering 121 drugs, with 679 brands recording price reductions of over 50% and the highest reduction being 96.45%.
•The revised prices are expected to generate annual consumer savings of approximately ₹3,540.38 crore.
•Consumers can verify prices through the Pharma Sahi Daam app or NPPA website, and report overcharging through the Pharma Jan Samadhan portal or NPPA helpline at 1800-111-255.
The detailed notification is given in the document below.
[Notification No.: 2334268]
